AbbVie ABBV
NYSE ABBV
$285.37 +1.97 (+0.70%)
As of: Oct 16, 2026 · 3:59 PM EDT

AbbVie (ABBV) Liabilities and Shareholders Equity (2012 - 2026)

Updated

AbbVie (ABBV) reported Liabilities and Shareholders Equity of $135.12 billion for Q2 2026, down 1.5% from $137.18 billion a year earlier and down 1.0% from the prior quarter.

Analysis

AbbVie (ABBV) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends

At the end of FY2025, AbbVie posted Liabilities and Shareholders Equity of $133.96 billion, down 0.9% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $135.16 billion in FY2024 (+0.3%), $134.71 billion in FY2023 (-2.9%), $138.81 billion in FY2022 (-5.3%) and $146.53 billion in FY2021 (-2.7%).
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $133.9 billion in Q3 2025 and a high of $148.87 billion in Q1 2024.
  • Year over year, Liabilities and Shareholders Equity gained in three of the last eight quarters, with an average decline of 1.9%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q1 2024 (growth of 10.7%); the low point was Q1 2025 (a decline of 8.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $136.46 billion (Q1 2026), $133.96 billion (Q4 2025) and $133.9 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 201.06 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 135.12 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 115.83 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 49.36 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 201.13 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 27.42 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 135.12 Bn
Mar 31, 2026 136.46 Bn
Dec 31, 2025 133.96 Bn
Sep 30, 2025 133.90 Bn
Jun 30, 2025 137.18 Bn
Mar 31, 2025 136.17 Bn
Dec 31, 2024 135.16 Bn
Sep 30, 2024 143.42 Bn
Jun 30, 2024 141.94 Bn
Mar 31, 2024 148.87 Bn
Dec 31, 2023 134.71 Bn
Sep 30, 2023 136.22 Bn
Jun 30, 2023 135.37 Bn
Mar 31, 2023 134.54 Bn
Dec 31, 2022 138.81 Bn
Sep 30, 2022 141.33 Bn
Jun 30, 2022 143.19 Bn
Mar 31, 2022 143.21 Bn
Dec 31, 2021 146.53 Bn
Sep 30, 2021 148.86 Bn
API Access

AbbVie Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ABBV&period=max&api_key=YOUR_API_KEY